SCHEMBL13977939

SCHEMBL13977939

C=N/C(=N\N=C/N)c1ccccn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CES2 O00748 1/20 0.39
▸ CES1 P23141 1/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ KMT2A Q03164 6/20 0.38
▸ NPC1 O15118 4/20 0.38
▸ RAB9A P51151 4/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ NAPRT Q6XQN6 1/20 0.38
▸ P4HTM Q9NXG6 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.37
▸ HDAC3 O15379 1/20 0.36
▸ HDAC4 P56524 1/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC7 Q8WUI4 1/20 0.36
▸ HDAC2 Q92769 1/20 0.36
▸ HDAC10 Q969S8 1/20 0.36
▸ HDAC11 Q96DB2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13978223 0.79 NPC1 (0.45) CES2CES1KDM4EKMT2ANPC1
SCHEMBL13977941 0.77 KDM4E (0.46) CES2CES1KDM4EKMT2ANPC1
SCHEMBL18909543 0.71 KDM4E (0.46) CES2CES1KDM4EKMT2ANPC1
SCHEMBL19889808 0.70 KDM4E (0.44) CES2CES1KDM4EKMT2ANPC1
SCHEMBL19785756 0.67 CES2 (0.50) CES2CES1KDM4EKMT2ANPC1
SCHEMBL21953560 0.67 KDM4E (0.48) CES2CES1KDM4EKMT2ANPC1
SCHEMBL18087488 0.66 CES2 (0.48) CES2CES1KDM4EKMT2ANPC1
SCHEMBL18653617 0.65 NPC1 (0.54) CES2CES1KDM4EKMT2ANPC1
SCHEMBL20903539 0.65 KDM4E (0.42) CES2CES1KDM4EKMT2ANPC1
SCHEMBL1255064 0.64 CES2 (0.56) CES2CES1KDM4EKMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023250157-A9 INHIBITORS OF MYCOBACTERIUM TUBERCULOSIS LIPOAMIDE DEHYDROGENASE CORNELL UNIVERSITY (US) 2024-01-25 — — WO disclosed
WO-2012156920-A1 BIO-ORTHOGONAL DRUG ACTIVATION KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) 2012-11-22 — — WO disclosed
Send feedback